• Innovative Approach for the
    Treatment of Epilepsy

    Neurolink is an early stage company developing a novel therapy for the treatment of epilepsy.

    Nearly three million Americans suffer from epilepsy, a neurological condition characterized by seizures. One of the most common neurological diseases, epilepsy affects approximately 1% of the population - 1 in 26 people will have epilepsy in their lifetime. While current therapies exist to control symptoms, for many patients, there is no ideal treatment due to limited efficacy and undesirable side effects.

    Learn More

Warning

We have been the target of employment/job scams. Unscrupulous persons are posing as representatives of our company offering job opportunities. They are asking for sensitive personal information including bank details and social security numbers. If you have any questions, please contact our HR department at 210.360.1681. Incidents should be reported to the FBI (http://www.ic3.gov/default.aspx) and the FTC (https://www.ftccomplaintassistant.gov/Information#&panel1-7).